Accessibility: Skip TopNav
TEVA ENROLLS PATIENTS FOR A SECOND LARGE GLOBAL PHASE III TRIAL OF ORAL LAQUINIMOD
16. Juli 2008 02:45 ET
| Quelle:
Active Biotech
Active Biotech
For release content, please refer to the attachment.
Anhänge
TEVA ENROLLS PATIENTS FOR A SECOND LARGE GLOBAL PHASE III TRIAL OF ORAL LAQUINIMOD ...